Stoke Therapeutics
STOK
STOK
81 hedge funds and large institutions have $255M invested in Stoke Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-15
Holders Change %
-15.63%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
27
Reduced
31
Closed
21
Calls
$5K
Puts
$4K
Net Calls
+$1K
Net Calls Change
-$264K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$35.5M |
| 2 |
Goldman Sachs
New York
|
$7.32M |
| 3 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
$15.6M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
$10.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.17M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
$13.8M |
| 2 |
RI
RTW Investments
New York
|
$21.7M |
| 3 |
Millennium Management
New York
|
$126K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$537K |
| 5 |
BlackRock
New York
|
$10.8M |
